
Research updates for the week of March 26 include a new clinical trial for Long Covid, a drug to protect immunocompromised people from Covid-19, and the intersections between Long Covid and HIV and hypermobility.

After NIH’s intramural ME study was published last month in the journal Nature Communications, some patient-advocates and experts in the ME community say their worst fears about this $8 million, eight-year research project were realized. In interviews with The Sick Times, advocates and experts shared concerns about which patients were included in the research, the…

Research updates for the week of March 19 include Covid-19’s potential impact on road deaths, a new drug trial, and alcohol sensitivity among people with Long Covid.

Research updates for the week of March 12 include newly-launched clinical trials from Scripps Research and NIH RECOVER, lingering SARS-CoV-2 fragments in blood and tissue, and healthcare workers with Long Covid.

Research updates for the week of March 5 include cognitive impairments from Covid-19, iron dysregulation, and differences between males and females with Long Covid.

Research updates for the week of February 27 include a major study about ME, persistent SARS-CoV-2 infections, and the blood brain barrier’s connection to brain fog.

PolyBio Research Foundation, a leading organization in supporting research for Long Covid and related chronic diseases, announced a new round of funding focused on identifying potential Long Covid treatments on Thursday. The research projects, which received a total of $15 million in funding, plan to study the potential biological underpinnings of Long Covid and begin…

Research updates for the week of February 20 include new funding for the NIH RECOVER initiative, research about hyperbaric oxygen therapy, and brain damage from Covid-19.

Research updates for the week of February 13 include mitochondrial dysfunction in people with Long Covid, risk of Long Covid among pregnant people, and the U.S.’s failure to protect frontline workers.

New studies published in the last week include “zombie fragments” from SARS-CoV-2, the burden of Covid-19 for BIPOC individuals, and a ME drug with promise for Long Covid.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance